Download Citation
Article Source:
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia
Leidinger P,
Keller A,
Milchram L,
Harz C,
Hart M,
et al.
(2015)
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia.
PLOS ONE 10(6): e0128235.
https://doi.org/10.1371/journal.pone.0128235